Evidence map›Paper›PMID 39492692›Full record

ArticleClinical and experimental immunology2025

Antigen-specific T-cell frequency and phenotype mirrors disease activity in DRB1*04:04+ rheumatoid arthritis patients.

Cliff Rims, Hannes Uchtenhagen, Kadin Brooks, Bernard Ng, Sylvia E Posso, Jeffrey Carlin, William W Kwok, Jane H Buckner, Eddie A James

Abstract read
In one paragraph

Article in Clinical and experimental immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Cliff RimsCenter for Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA, USA.ORCID 0009-0003-0342-4378
Hannes UchtenhagenCenter for Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA, USA.
Kadin BrooksCenter for Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA, USA.
Bernard NgVA National Rheumatology Program, Specialty Care Program Office, Washington DC, USA.
Sylvia E PossoCenter for Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA, USA.ORCID 0000-0002-6572-4291
Jeffrey CarlinDepartment of Rheumatology, Virginia Mason Medical Center, Seattle, WA, USA.ORCID 0009-0006-5634-1981
William W KwokCenter for Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA, USA.ORCID 0000-0003-4843-4599
Jane H BucknerCenter for Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA, USA.ORCID 0000-0002-9005-1885
Eddie A JamesCenter for Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA, USA.ORCID 0000-0002-7217-5729

Funding

Unmodified and Post Translationally Modified CD4+ and CD8+ T cell Epitopes in Rheumatoid Arthritis75N93019C00068 · NIAID · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI BENTON, RYAN · 2019 to 2023
$5.4M
NIAID NIH HHS 75N93019C00068Peer Reviewed Medical Research Program W81XWH-15-1-0003
6 · The paper itself

Abstract

Rheumatoid arthritis (RA) is associated with high-risk HLA class II alleles known as the "RA shared epitope." Among prevalent shared epitope alleles, study of DRB1*04:04 has been limited. To define relevant epitopes, we identified citrullinated peptide sequences from synovial antigens that were predicted to bind to HLA-DRB1*04:04 and utilized a systematic approach to confirm their binding and assess their recognition by CD4 T cells. After confirming the immunogenicity of 13 peptides derived from aggrecan, cartilage intermediate layer protein (CILP), α-enolase, vimentin, and fibrinogen, we assessed their recognition by T cells from a synovial tissue sample, observing measurable responses to 8 of the 13 peptides. We then implemented a multicolor tetramer panel to evaluate the frequency and phenotype of antigen-specific CD4 T cells in individuals with anti-citrullinated protein antibody-positive RA and controls. In subjects with RA, CILP-specific T-cell frequencies were significantly higher than those of other antigens. The surface phenotypes exhibited by antigen-specific T cells were heterogeneous, but Th1-like and Th2-like cells predominated. Stratifying based on disease status and activity, antigen-specific T cells were more frequent and most strongly polarized in RA subjects with high disease activity. In total, these findings identify novel citrullinated epitopes that can be used to interrogate antigen-specific CD4 T cells and show that antigen-specific T-cell frequency is elevated in subjects with high disease activity.

Indexed as

Arthritis, RheumatoidCD4-Positive T-LymphocytesEpitopes, T-LymphocyteHLA-DRB1 ChainsAdultAgedAggrecansAnti-Citrullinated Protein AntibodiesFemaleHumansMaleMiddle AgedPhenotypeTh1 CellsAggrecansAnti-Citrullinated Protein AntibodiesEpitopes, T-LymphocyteHLA-DRB1 Chainsautoimmunitycitrullinedisease activiryrheumatoid arthritisshared epitopeT cell

Identifiers

PMID39492692
PMCPMC11754868

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.